These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9402520)

  • 1. Left ventricular assist devices: permanent implant versus bridge to transplantation--is either cost-effective?
    Evans RW
    J Heart Lung Transplant; 1997 Nov; 16(11):1180-5. PubMed ID: 9402520
    [No Abstract]   [Full Text] [Related]  

  • 2. Implantable ventricular assist devices: is it time to introduce them in Canada?
    McGregor M
    Can J Cardiol; 2000 May; 16(5):629-40. PubMed ID: 10833542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs associated with ventricular assist device use in children.
    Mahle WT; Ianucci G; Vincent RN; Kanter KR
    Ann Thorac Surg; 2008 Nov; 86(5):1592-7. PubMed ID: 19049755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart transplant and left ventricular assist device costs.
    Digiorgi PL; Reel MS; Thornton B; Burton E; Naka Y; Oz MC
    J Heart Lung Transplant; 2005 Feb; 24(2):200-4. PubMed ID: 15701438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart transplant and left ventricular assist device costs.
    Bostic RR
    J Heart Lung Transplant; 2005 Nov; 24(11):1997-8. PubMed ID: 16297815
    [No Abstract]   [Full Text] [Related]  

  • 6. [Economic aspects of implementation of the mechanical heart, "HeartMate"].
    Kolbye A; Sander Jensen KM; Aldershvile J; Hansen PB; Kjersem AM; Nielsen KS; Olsen PS; Rasmussen B; Vogelsang G
    Ugeskr Laeger; 2000 Jun; 162(26):3722-5. PubMed ID: 10925632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost considerations for long-term mechanical circulatory support.
    Oz MC; Grewal R; Gelijn A
    ASAIO J; 1997; 43(4):268-70. PubMed ID: 9242938
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness in patients awaiting transplantation receiving intravenous inotropic support.
    Loisance D; Sailly JC
    Eur J Anaesthesiol Suppl; 1993; 8():9-13. PubMed ID: 8223355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of left ventricular-assist devices in end-stage heart failure.
    Hutchinson J; Scott DA; Clegg AJ; Loveman E; Royle P; Bryant J; Colquitt JL
    Expert Rev Cardiovasc Ther; 2008 Feb; 6(2):175-85. PubMed ID: 18248272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival.
    Cleveland JC; Grover FL; Fullerton DA; Campbell DN; Mitchell MB; Lindenfeld J; Wolfel EE; Lowes BD; Shakar SF; Brieke A; Cannon A; Robertson AD
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):774-7. PubMed ID: 18805284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assist device: can Canada afford this?
    Carrier M
    Can J Cardiol; 2005 Nov; 21(13):1166-8. PubMed ID: 16308591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical circulatory support systems: ethical considerations.
    Levine RJ
    Transplant Proc; 1990 Jun; 22(3):969-70. PubMed ID: 2112283
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of an inexpensive blue band during ventricular assist device and total artificial heart placement facilitates and expedites explantation during heart transplant.
    Jaroszewski DE; Lackey JJ; Lanza LA; DeValeria PA; Arabia FA
    Ann Thorac Surg; 2009 May; 87(5):1623-4. PubMed ID: 19379933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances and perspectives in mechanical heart assist].
    Loebe M; Potapov E; Drews T; Weng Y; Ngo W; Grafin zu Dohna R; Müller J; Sodian R; Hetzer R
    Z Kardiol; 2000; 89 Suppl 7():91-8. PubMed ID: 11098565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of ventricular assist devices: can we afford the progress?
    Miller LW; Guglin M; Rogers J
    Circulation; 2013 Feb; 127(6):743-8. PubMed ID: 23401115
    [No Abstract]   [Full Text] [Related]  

  • 18. Good news and bad news: the cost of mending a broken heart.
    Williams D
    Med Device Technol; 2003; 14(1):8-10. PubMed ID: 12974118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital and physician partnership in the acquisition and use of high-cost niche technology.
    Rieger MW
    J Cardiovasc Manag; 1996; 7(4):17-8, 20. PubMed ID: 10159787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial left ventricular support implanted through minimal access surgery as a bridge to cardiac transplant.
    Meyns B; Rega F; Ector J; Droogne W; Vanhaecke J; Van Hemelrijck J; Griffith B; Dowling R; Zucker M; Burkhoff D
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):243-5. PubMed ID: 19154933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.